Stocktoria

VERACYTE, INC. VCYT

Nasdaq · stock · Services-Medical Laboratories · website · IPO 2013-10-30 · LEI

VERACYTE, INC. financials (annual)

Revenue
$65.1M $72.0M $92.0M $120.4M $117.5M $219.5M $296.5M $361.1M $445.8M $517.1M 2016201720182019202020212022202320242025
Net income
-$23.0M -$12.6M -$34.9M -$75.6M -$36.6M -$74.4M $24.1M $66.4M 2016201720182019202020212022202320242025
Free cash flow
-$32.2M -$25.7M -$15.4M -$6.0M -$12.5M -$37.0M -$1.0M $34.3M $63.8M $126.6M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$517.1M$445.8M$361.1M$296.5M$219.5M$117.5M$120.4M$92.0M$72.0M$65.1M
Gross profit$362.5M$298.1M$229.7M$175.7M
R&D expense$70.8M$69.3M$57.3M$40.6M$29.8M$17.2M$14.9M$14.8M$13.9M$15.3M
Operating income$57.8M$16.1M-$85.8M-$41.1M-$81.9M-$35.4M-$15.1M-$22.2M-$26.5M-$28.8M
Interest expense$229,000$677,000$2.0M$4.9M$2.8M
Income tax$1.8M$1.6M-$2.2M$133,000-$6.1M$0$0$0$0$0
Net income$66.4M$24.1M-$74.4M-$36.6M-$75.6M-$34.9M-$12.6M-$23.0M
EPS (diluted)$0.82$0.31$-1.02$-0.51$-1.11$-0.66$-0.27
Operating cash flow$136.3M$75.1M$44.2M$7.5M-$31.6M-$9.7M-$3.2M-$13.5M-$23.9M-$28.0M
Free cash flow$126.6M$63.8M$34.3M-$1.0M-$37.0M-$12.5M-$6.0M-$15.4M-$25.7M-$32.2M
Cash & equivalents$362.6M$239.1M$216.5M$154.2M$173.2M$349.4M$159.3M$78.0M$33.9M$59.2M
Inventory$20.5M$21.8M$16.1M$14.3M$11.2M$4.7M$6.8M$3.4M$5.3M$3.5M
Total assets$1.4B$1.3B$1.1B$1.2B$1.2B$457.2M$275.2M$120.6M$78.7M$101.0M
Total liabilities$96.4M$124.1M$70.8M$81.2M$91.3M$35.9M$35.8M$40.9M$41.4M$41.5M
Shareholders' equity$1.3B$1.2B$1.0B$1.1B$1.1B$421.2M$239.5M$79.8M$37.2M$59.6M

Growth · year-over-year · Revenue CAGR 25.9%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth+16.0%+23.5%+21.8%+35.1%+86.8%-2.4%+30.8%+27.9%+10.6%+31.5%
Net income growth+174.9%
EPS growth+164.5%
Free cash flow growth+98.5%+86.2%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.